Found: 42
Select item for more details and to access through your institution.
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 252, doi. 10.1038/leu.2012.172
- By:
- Publication type:
- Article
Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Time-variations of pretreatment peripheral blood S + G2/M-phase size determined by flow cytometry in adult acute myeloid leukaemia.
- Published in:
- European Journal of Haematology, 1990, v. 45, n. 1, p. 5, doi. 10.1111/j.1600-0609.1990.tb00406.x
- By:
- Publication type:
- Article
Ultrasound-guided intermediate cervical plexus block for carotid endarterectomy using a new anterior approach: a two-centre prospective observational study.
- Published in:
- Anaesthesia, 2015, v. 70, n. 4, p. 445, doi. 10.1111/anae.12960
- By:
- Publication type:
- Article
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 542, doi. 10.1038/bmt.2011.117
- By:
- Publication type:
- Article
Development of a criterion for response to therapy at 6 months in multiple myeloma.
- Published in:
- European Journal of Haematology, 1995, v. 55, n. 2, p. 110, doi. 10.1111/j.1600-0609.1995.tb01819.x
- By:
- Publication type:
- Article
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Peroxysome proliferator-activated receptors’ gene expression in Type 2 diabetic atheroma.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma.
- Published in:
- Case Reports in Hematology, 2019, p. 1, doi. 10.1155/2019/7609308
- By:
- Publication type:
- Article
Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 7, p. 733, doi. 10.1038/sj.bmt.1704211
- By:
- Publication type:
- Article
Interference of blast cell fragments with automated platelet counting.
- Published in:
- International Journal of Laboratory Hematology, 2015, v. 37, n. 5, p. 613, doi. 10.1111/ijlh.12371
- By:
- Publication type:
- Article
Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
- Published in:
- International Journal of Laboratory Hematology, 2015, v. 37, n. 4, p. 486, doi. 10.1111/ijlh.12315
- By:
- Publication type:
- Article
KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 838, doi. 10.1002/hon.3166_OT18
- By:
- Publication type:
- Article
AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 147, doi. 10.1002/hon.3163_97
- By:
- Publication type:
- Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 94, doi. 10.1002/hon.3163_58
- By:
- Publication type:
- Article
EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA : RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 179, doi. 10.1002/hon.3163_113
- By:
- Publication type:
- Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.88_2880
- By:
- Publication type:
- Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.87_2880
- By:
- Publication type:
- Article
PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.79_2879
- By:
- Publication type:
- Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.57_2880
- By:
- Publication type:
- Article
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.5_2879
- By:
- Publication type:
- Article
CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.3_2880
- By:
- Publication type:
- Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
- By:
- Publication type:
- Article
BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS WITH STAGE I/II CLASSICAL HODGKIN'S LYMPHOMA AND A POSITIVE FDG‐PET AFTER 2 CYCLES OF ABVD: A LYSA PHASE 2 STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.111_2880
- By:
- Publication type:
- Article
IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 135, doi. 10.1002/hon.95_2629
- By:
- Publication type:
- Article
RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 117, doi. 10.1002/hon.77_2629
- By:
- Publication type:
- Article
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 49, doi. 10.1002/hon.19_2629
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF ATEZOLIZUMAB, OBINUTUZUMAB AND VENETOCLAX COMBINATION FOR RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMAS: RESULTS FROM THE SAFETY‐RUN OF A LYSA STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 332, doi. 10.1002/hon.144_2630
- By:
- Publication type:
- Article
IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 135, doi. 10.1002/hon.95_2629
- By:
- Publication type:
- Article
RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 117, doi. 10.1002/hon.77_2629
- By:
- Publication type:
- Article
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 49, doi. 10.1002/hon.19_2629
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF ATEZOLIZUMAB, OBINUTUZUMAB AND VENETOCLAX COMBINATION FOR RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMAS: RESULTS FROM THE SAFETY‐RUN OF A LYSA STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 332, doi. 10.1002/hon.144_2630
- By:
- Publication type:
- Article
FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 141, doi. 10.1002/hon.2437_131
- By:
- Publication type:
- Article
GENE-EXPRESSION PROFILING PREDICTS DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 113, doi. 10.1002/hon.2437_103
- By:
- Publication type:
- Article
Rituximab maintenance after autologous stem-cell transplantation in patients with mantle cell lymphoma, final result of the LyMA trial conducted on behalf the LYSA group.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 209, doi. 10.1002/hon.2438_74
- By:
- Publication type:
- Article
MCL-R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R-CHOP / R-HAD) AND a RITUXIMAB-LENALIDOMIDE MAINTENANCE.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 421, doi. 10.1002/hon.2440_3
- By:
- Publication type:
- Article
EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 96, doi. 10.1002/hon.2437_85
- By:
- Publication type:
- Article
A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B-CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 52, doi. 10.1002/hon.2437_36
- By:
- Publication type:
- Article
Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.
- Published in:
- Langenbeck's Archives of Surgery, 2016, v. 401, n. 8, p. 1131, doi. 10.1007/s00423-016-1488-y
- By:
- Publication type:
- Article